Literature DB >> 11876549

Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis.

H Kuniyasu1, N Oue, H Shigeishi, R Ito, Y Kato, H Yokozaki, W Yasui.   

Abstract

Multivariate regression analysis has shown that Ki-67 labeling index in the mucosa adjacent to cancer was the most significant marker for colorectal cancer metastasis among several metastasis-related parameters according to our previous retrospective data base (7). We have performed a prospective study to ascertain whether Ki-67 labeling index in the mucosa adjacent to cancer is a useful preoperative diagnostic marker for colorectal cancer metastasis. In 182 registered cases colonoscopically biopsied, we performed surgical resection of the cancer in 37 adenocarcinoma cases, which were registered in the study. In 31 out of the 37 cases except for 6 cases with an insufficient amount of non-neoplastic mucosa, preoperative diagnosis for metastasis was performed using the Ki-67 cutoff line. The cutoff line was set at 15% according to our previous retrospective database. The preoperative diagnosis for metastasis was compared to the pathological findings of the resected specimen. The incidences of correct diagnosis for metastasis was 81% (25/31). There were 3 false positive cases and 3 false negative cases in Dukes' A-B and Dukes' C, respectively. The mean Ki-67 labeling index in the mucosa adjacent to cancer of Dukes' A-B and Dukes' C-D cases, except for the 6 misdiagnosed cases, was 7.4+/-5.0% and 29.9+9.8%, being significant at p<0.0001 by unpaired Mann-Whitney U test. These results suggest that Ki-67 labeling index in the mucosa adjacent to cancer might be a good marker for metastasis in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11876549

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  4 in total

1.  Mitochondrial DNA Integrity Is Maintained by APE1 in Carcinogen-Induced Colorectal Cancer.

Authors:  Joan Ballista-Hernández; Margaly Martínez-Ferrer; Roman Vélez; Consuelo Climent; Maria M Sánchez-Vázquez; Ceidy Torres; Adlin Rodríguez-Muñoz; Sylvette Ayala-Peña; Carlos A Torres-Ramos
Journal:  Mol Cancer Res       Date:  2017-03-30       Impact factor: 5.852

2.  Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis.

Authors:  Wei Shi; Jiangfeng Hu; Shizhang Zhu; Xiaoying Shen; Xiaoyan Zhang; Changqing Yang; Hengjun Gao; Hao Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.

Authors:  Yvonne Wettergren; Elisabeth Odin; Staffan Nilsson; Göran Carlsson; Bengt Gustavsson
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

4.  Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC.

Authors:  Saieh Hajighasemlou; Mohsen Nikbakht; Saeedreza Pakzad; Samad Muhammadnejad; Safoora Gharibzadeh; Milad Mirmoghtadaei; Fariba Zafari; Iman Seyhoun; Jafar Ai; Javad Verdi
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-14       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.